Neutralizing Antibody Assay Using PEG Precipitation Against Drug Interference
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing neutralizing antibody (NAb) assays face challenges due to drug interference, leading to false negative or positive results, and require complex and costly methods like Bead Extraction and Acid Dissociation (BEAD) that can denature antibodies, especially for high-dose, long-half-life monoclonal antibody drugs.
Innovation Solution
A method called PEG Precipitation, Acid Dissociation, and Biotin-drug as Assay Drug (PABAD) is introduced, which uses PEG precipitation to separate drug-antibody complexes, followed by mild acid treatment and biotin-labeled drug to detect NAbs without magnetic beads, reducing complexity and cost.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If Bead Extraction and Acid Dissociation (BEAD) is used to overcome drug interference, then NAb detection accuracy is improved, but antibody denaturation occurs and assay complexity increases
Solution Approach 1:
The patent extracts and removes free drug from the sample using PEG precipitation before the NAb detection assay. By precipitating drug-antibody complexes and separating them from free drug, the method eliminates drug interference without requiring harsh acid treatment that would denature antibodies. This extraction step directly addresses the contradiction by removing the harmful factor (free drug) while preserving the integrity of NAbs.
Solution Approach 2:
The patent changes the physical state of drug-antibody complexes from dissolved to precipitated form using PEG. This parameter change allows selective removal of free drug while maintaining antibody integrity. The precipitation process alters the solubility parameters of the complexes, enabling separation without denaturation, thus resolving the contradiction between removing drug interference and preserving antibody structure.
2Measurement precision
If BEAD method is used to enrich NAbs, then NAb detection sensitivity is improved, but reagent cost and assay complexity increase
Solution Approach 1:
The patent uses PEG precipitation to extract and remove free drug from the sample, simplifying the assay protocol by eliminating the need for magnetic beads and complex acid dissociation steps. This extraction approach achieves NAb enrichment indirectly by removing interfering substances, thereby reducing assay complexity while maintaining sensitivity.
Solution Approach 2:
The patent replaces expensive magnetic beads and complex reagent systems with a simpler, more economical PEG precipitation system. The PEG method uses readily available reagents and straightforward centrifugation steps, reducing both reagent cost and operational complexity while achieving the same NAb detection sensitivity.
3Productivity
If harsh acid treatment is applied during BEAD assay, then drug-antibody complex dissociation is improved, but acid-sensitive NAbs are denatured
Solution Approach 1:
The patent extracts free drug from the sample using PEG precipitation, eliminating the need for harsh acid treatment to dissociate complexes. By removing free drug before the assay, the method achieves complex dissociation indirectly through a gentler process, preserving NAb activity while maintaining productivity.
Solution Approach 2:
The patent uses PEG as an intermediary substance to facilitate drug-antibody complex separation without requiring harsh acid. PEG acts as a mild agent that precipitates complexes and enables their separation, serving as a mediator that achieves dissociation goals while protecting acid-sensitive NAbs from denaturation.
4Reliability
If high molar ratio of drug to NAb is present in sample, then therapeutic efficacy is maintained, but false negative readout occurs
Solution Approach 1:
The patent extracts and removes free drug from the sample using PEG precipitation, creating a purified sample where NAb can be accurately detected even when the original sample contained high molar ratios of drug to NAb. This extraction step eliminates the competition between drug and NAb for binding sites, resolving the contradiction between maintaining therapeutic drug levels and achieving accurate NAb detection.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The PABAD method provides accurate NAb detection with reduced reagent use, avoids antibody denaturation, and improves assay sensitivity and specificity by eliminating drug interference.
Implementation Method 1
contacting the sample with the drug to bind any anti-drug antibody (ADA) not already bound to the drug in the sample, precipitating the bound ADA/drug complexes
Implementation Method 2
dissociating the ADA/drug complex precipitate with a mild acid solution to yield a mixture comprising free drug and free ADA
Implementation Method 3
contacting the mixture with the drug having a label to allow the labeled drug to bind to the free ADA to yield labeled ADA/drug complexes
Data Source
AI summary
This disclosure relates generally to an assay to determine the presence of neutralizing antibody (NAb) in a sample of a subject treated with a drug.